Literature DB >> 277270

Proliferative state of blast cell progenitors in acute myeloblastic leukemia (AML).

M D Minden, J E Till, E A McCulloch.   

Abstract

Peripheral blood from patients with acute myeloblastic leukemia (AML) contains cells capable of giving rise to colonies in culture when stimulated by media conditioned by leukocytes (LCM) in the presence of phytohemagglutinin (PHA). Two types of colonies are recognized with high frequency: The first grows in the presence of low concentrations of PHA LCM, have a blast-like morphology, and are numerically correlated with morphologically identified blast cells. The second requires either high PHA LCM concentrations or PHA alone with or without 2-mercaptoethanol and consists of cells capable of forming rossettes with sheep erythrocytes and resembles. T-lymphocyte colonies from normal blood. Precursors of blast cell colonies from 15 leukemic patients were tested for cycle state, using either the 3H-thymidine or hydroxyurea techniques. All were found to have a high proportion of cells in the S phase of the cycle. In contrast, T lymphocyte precursors from three normal individual were quiescent. The data are consistent with the maintenance of the leukemic blast cell populations by the proliferative activity of a small subpopulation of blasts.

Entities:  

Mesh:

Year:  1978        PMID: 277270

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Int J Hematol       Date:  2010-05-08       Impact factor: 2.490

2.  A characterization of T lymphocyte colony-forming cells (TL-CFC) in human bone marrow.

Authors:  K Swart; B Löwenberg
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

3.  Value of colony forming unit-granulocyte macrophage assay in predicting relapse in acute myeloid leukaemia.

Authors:  M C del Cañizo; A Mota; A Orfao; J Galende; M D Caballero; M A Garcia Marcos; J F San Miguel
Journal:  J Clin Pathol       Date:  1996-06       Impact factor: 3.411

4.  Differential response to cytotoxic therapy explains treatment dynamics of acute myeloid leukaemia patients: insights from a mathematical modelling approach.

Authors:  H Hoffmann; C Thiede; I Glauche; M Bornhaeuser; I Roeder
Journal:  J R Soc Interface       Date:  2020-09-09       Impact factor: 4.118

5.  A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.

Authors:  Suraj Bansal; Liqing Jin; Andy G X Zeng; Amanda Mitchell; Weihsu Claire Chen; Hussein A Abbas; Michelle Chan-Seng-Yue; Veronique Voisin; Peter van Galen; Anne Tierens; Meyling Cheok; Claude Preudhomme; Hervé Dombret; Naval Daver; P Andrew Futreal; Mark D Minden; James A Kennedy; Jean C Y Wang; John E Dick
Journal:  Nat Med       Date:  2022-05-26       Impact factor: 87.241

6.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.

Authors:  D C Young; K Wagner; J D Griffin
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

8.  In vitro response of blasts to IL-3, GM-CSF, and G-CSF is different for individual AML patients: factors that stimulate leukemic clonogenic cells also enhance Ara-C cytotoxicity.

Authors:  N Van der Lely; T De Witte; J Wessels; R Raymakers; P Muus; F Preijers
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

9.  Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells.

Authors:  David J H F Knapp; Colin A Hammond; Paul H Miller; Gabrielle M Rabu; Philip A Beer; Marketa Ricicova; Véronique Lecault; Daniel Da Costa; Michael VanInsberghe; Alice M Cheung; Davide Pellacani; James Piret; Carl Hansen; Connie J Eaves
Journal:  Stem Cell Reports       Date:  2017-01-10       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.